The price of weight loss drugs is falling, making them more accessible to consumers, and the price could get driven even ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Facing steep competition, Novo Nordisk has slashed the price for its weight loss drug Wegovy — temporarily, at least.

STANDING on the scales Clare Macnaughton lets out a howl of frustration as they stubbornly land on 16st 7lbs.  For seven ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...

A charming mix of playful and vintage, this mini dress serves up serious prairie-core energy. The milkmaid neckline and ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the sovereign credit rating ...